Search

everythinglearnresearchcommunity

for

Search:↓

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

The proteins transthyretin and megalin are more present in the growth phase of hair, suggesting they might affect hair health and growth.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

Tirzepatide may improve hair loss by reducing insulin resistance.

People with Alopecia Areata often have thyroid problems like Hashimoto thyroiditis and hypothyroidism.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Generalized trichoepitheliomas with hair loss may indicate myasthenia gravis.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Canine hypothyroidism often causes skin issues like hair loss.